194 related articles for article (PubMed ID: 24465478)
1. A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology.
Padberg I; Peter E; González-Maldonado S; Witt H; Mueller M; Weis T; Bethan B; Liebenberg V; Wiemer J; Katus HA; Rein D; Schatz P
PLoS One; 2014; 9(1):e85082. PubMed ID: 24465478
[TBL] [Abstract][Full Text] [Related]
2. Glyoxylate, a new marker metabolite of type 2 diabetes.
Nikiforova VJ; Giesbertz P; Wiemer J; Bethan B; Looser R; Liebenberg V; Ruiz Noppinger P; Daniel H; Rein D
J Diabetes Res; 2014; 2014():685204. PubMed ID: 25525609
[TBL] [Abstract][Full Text] [Related]
3. Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolism.
Hernández-Alvarez MI; Díaz-Ramos A; Berdasco M; Cobb J; Planet E; Cooper D; Pazderska A; Wanic K; O'Hanlon D; Gomez A; de la Ballina LR; Esteller M; Palacin M; O'Gorman DJ; Nolan JJ; Zorzano A
Sci Rep; 2017 Oct; 7(1):13850. PubMed ID: 29062026
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes.
Giesbertz P; Padberg I; Rein D; Ecker J; Höfle AS; Spanier B; Daniel H
Diabetologia; 2015 Sep; 58(9):2133-43. PubMed ID: 26058503
[TBL] [Abstract][Full Text] [Related]
5. Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications.
Li X; Li Y; Liang Y; Hu R; Xu W; Liu Y
Diabetes Metab J; 2021 Mar; 45(2):195-208. PubMed ID: 33685035
[TBL] [Abstract][Full Text] [Related]
6. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
7. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.
Lai M; Liu Y; Ronnett GV; Wu A; Cox BJ; Dai FF; Röst HL; Gunderson EP; Wheeler MB
PLoS Med; 2020 May; 17(5):e1003112. PubMed ID: 32433647
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity.
Yoshinaga H; Kosaka K
Diabetes Res Clin Pract; 1999 May; 44(2):129-36. PubMed ID: 10414932
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
10. Integration of whole-body [
Diamanti K; Visvanathar R; Pereira MJ; Cavalli M; Pan G; Kumar C; Skrtic S; Risérus U; Eriksson JW; Kullberg J; Komorowski J; Wadelius C; Ahlström H
Sci Rep; 2020 May; 10(1):8343. PubMed ID: 32433479
[TBL] [Abstract][Full Text] [Related]
11. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
[TBL] [Abstract][Full Text] [Related]
12. Cellular glucose transport disturbances as a marker of the pre-diabetic state - pathogenetic and clinical significance of the assessment of GLUT4 expression.
Bernat-Karpińska M; Czech A; Piatkiewicz P; Wierzbicki P; Górski A
Endokrynol Pol; 2010; 61(3):269-74. PubMed ID: 20602301
[TBL] [Abstract][Full Text] [Related]
13. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.
Xu F; Tavintharan S; Sum CF; Woon K; Lim SC; Ong CN
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1060-5. PubMed ID: 23633210
[TBL] [Abstract][Full Text] [Related]
14. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
Gogna N; Krishna M; Oommen AM; Dorai K
Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes.
Tulipani S; Palau-Rodriguez M; Miñarro Alonso A; Cardona F; Marco-Ramell A; Zonja B; Lopez de Alda M; Muñoz-Garach A; Sanchez-Pla A; Tinahones FJ; Andres-Lacueva C
Clin Chim Acta; 2016 Dec; 463():53-61. PubMed ID: 27720726
[TBL] [Abstract][Full Text] [Related]
16. Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
Duflot T; Moreau-Grangé L; Roche C; Iacob M; Wils J; Rémy-Jouet I; Cailleux AF; Leuillier M; Renet S; Li D; Morisseau C; Lamoureux F; Richard V; Prévost G; Joannidès R; Bellien J
Cardiovasc Diabetol; 2019 Mar; 18(1):35. PubMed ID: 30885203
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.
Menni C; Fauman E; Erte I; Perry JR; Kastenmüller G; Shin SY; Petersen AK; Hyde C; Psatha M; Ward KJ; Yuan W; Milburn M; Palmer CN; Frayling TM; Trimmer J; Bell JT; Gieger C; Mohney RP; Brosnan MJ; Suhre K; Soranzo N; Spector TD
Diabetes; 2013 Dec; 62(12):4270-6. PubMed ID: 23884885
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
[TBL] [Abstract][Full Text] [Related]
19. A glimpse of the 'natural history' of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis.
Coates PA; Ollerton RL; Luzio SD; Ismail I; Owens DR
Diabetes Res Clin Pract; 1994 Dec; 26(3):177-87. PubMed ID: 7736898
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
